(Reuters) – GlaxoSmithKline <GSK.L> said on Thursday it agreed to sell its entire stake in Unilever’s <ULVR.L> Indian business <HLL.NS> for about 254.8 billion rupees ($3.35 billion) on the open market, cashing in late from the sale of the Horlicks brand. (https://reut.rs/3fvie8r)
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Anil D’Silva)
Defending champ Golden Knights to face top-seeded Stars in playoffs after 4-1 loss to Ducks
Utah and Florida clinch final two spots at NCAA championship, denying Oklahoma’s bid for three-peat
Chasing 5th straight win, Nelly Korda is 2 shots back at Chevron Championship after a first-round 68
Kawhi Leonard fighting ‘stubborn inflammation’ and is questionable for Game 1 of playoffs
Scheffler wiped out from Masters and opens with a 69 at Hilton Head. He trails Poston by 6 shots
Laborers and street vendors in Mali find no respite as deadly heat wave surges through West Africa
Iran fires air defense batteries at Isfahan air base and nuclear site after drones spotted
Indians vote in the first phase of the world’s largest election as Modi seeks a third term
Russia pummels exhausted Ukrainian forces with smaller attacks ahead of a springtime advance
BNSF Railway says it didn’t know about asbestos that’s killed hundreds in Montana town
City Council approves zoning changes to legalize casinos in the Big Apple
Cannabis 101: Confused by New York’s marijuana laws? Here’s what you need to know ahead of 4/20Samuel Waxman Cancer Research Foundation brings New York power-brokers together for fundraiserSign of the times: Why vacant storefronts continue to plague NYC
